Uploaded August 2026 | Updated November 2026, 3 hours ago
Following the public announcement of SpaceMD’s first commercial Starfall mission with SpaceX, Redwire will host an in‑depth industry event to discuss how this milestone marks a transformational moment for biotech, in-space manufacturing, and the emerging space-enabled economy. Public and private sector leaders as well as trailblazing researchers will describe how microgravity can transform both the space and pharmaceutical / biotech fields.
Speakers Include:
- Mike Gold, President, Redwire Space
- John Vellinger, CEO, SpaceMD
- Taylor Jordan, Director, Office of Space Commerce
- Gabriel Swiney, Deputy Director, Office of Space Commerce
- Paul Reichert, Former Principal Investigator, Merck Research Laboratories
- Catriona Jamieson, MD, PhD, Founder and Board Member, Aspera Biomedicines
- John Thompson, Deputy Assistant Secretary for Space and Environment, Department of State
Following the public announcement of SpaceMD’s first commercial Starfall mission with SpaceX, Redwire will host an in‑depth industry event to discuss how this milestone marks a transformational moment for biotech, in-space manufacturing, and the emerging space-enabled economy. Public and private sector leaders as well as trailblazing researchers will describe how microgravity can transform both the space and pharmaceutical / biotech fields.
Speakers Include:
- Mike Gold, President, Redwire Space
- John Vellinger, CEO, SpaceMD
- Taylor Jordan, Director, Office of Space Commerce
- Gabriel Swiney, Deputy Director, Office of Space Commerce
- Paul Reichert, Former Principal Investigator, Merck Research Laboratories
- Catriona Jamieson, MD, PhD, Founder and Board Member, Aspera Biomedicines
- John Thompson, Deputy Assistant Secretary for Space and Environment, Department of State










